251 related articles for article (PubMed ID: 36824351)
21. Insights on the Formulation of Recombinant Proteins.
Ribeiro R; Abreu TR; Silva AC; Gonçalves J; Moreira JN
Adv Biochem Eng Biotechnol; 2020; 171():23-54. PubMed ID: 31844925
[TBL] [Abstract][Full Text] [Related]
22. Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.
Cun D; Wan F; Yang M
Curr Pharm Des; 2015; 21(19):2599-610. PubMed ID: 25876915
[TBL] [Abstract][Full Text] [Related]
23. Improving the extraction and purification of immunoglobulin G by the use of ionic liquids as adjuvants in aqueous biphasic systems.
Ferreira AM; Faustino VFM; Mondal D; Coutinho JAP; Freire MG
J Biotechnol; 2016 Oct; 236():166-175. PubMed ID: 27568168
[TBL] [Abstract][Full Text] [Related]
24. Excipients in freeze-dried biopharmaceuticals: Contributions toward formulation stability and lyophilisation cycle optimisation.
Bjelošević M; Zvonar Pobirk A; Planinšek O; Ahlin Grabnar P
Int J Pharm; 2020 Feb; 576():119029. PubMed ID: 31953087
[TBL] [Abstract][Full Text] [Related]
25. Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances.
Vicente T; Mota JP; Peixoto C; Alves PM; Carrondo MJ
Biotechnol Adv; 2011; 29(6):869-78. PubMed ID: 21784144
[TBL] [Abstract][Full Text] [Related]
26. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
Buckley K; Ryder AG
Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
[TBL] [Abstract][Full Text] [Related]
27. Formulation and stability of cytokine therapeutics.
Lipiäinen T; Peltoniemi M; Sarkhel S; Yrjönen T; Vuorela H; Urtti A; Juppo A
J Pharm Sci; 2015 Feb; 104(2):307-26. PubMed ID: 25492409
[TBL] [Abstract][Full Text] [Related]
28. Immune-Modulating Lipid Nanomaterials for the Delivery of Biopharmaceuticals.
Kim S; Choi B; Kim Y; Shim G
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376208
[TBL] [Abstract][Full Text] [Related]
29. Applications of Ionic Liquids in Carboxylic Acids Separation.
Blaga AC; Tucaliuc A; Kloetzer L
Membranes (Basel); 2022 Aug; 12(8):. PubMed ID: 36005686
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic platform for rapid screening of bacterial cell lysis.
Fradique R; Azevedo AM; Chu V; Conde JP; Aires-Barros MR
J Chromatogr A; 2020 Jan; 1610():460539. PubMed ID: 31543341
[TBL] [Abstract][Full Text] [Related]
31. Status and future developments for downstream processing of biological products: Perspectives from the Recovery XIX yield roundtable discussions.
Jungbauer A; Ferreira G; Butler M; D'Costa S; Brower K; Rayat A; Willson R
Biotechnol Bioeng; 2024 May; ():. PubMed ID: 38795025
[TBL] [Abstract][Full Text] [Related]
32. Automated ion exchange chromatography screening combined with in silico multifactorial simulation for efficient method development and purification of biopharmaceutical targets.
Losacco GL; Hicks MB; DaSilva JO; Wang H; Potapenko M; Tsay FR; Ahmad IAH; Mangion I; Guillarme D; Regalado EL
Anal Bioanal Chem; 2022 May; 414(12):3581-3591. PubMed ID: 35441858
[TBL] [Abstract][Full Text] [Related]
33. Emerging biomaterials for downstream manufacturing of therapeutic proteins.
Li Y; Stern D; Lock LL; Mills J; Ou SH; Morrow M; Xu X; Ghose S; Li ZJ; Cui H
Acta Biomater; 2019 Sep; 95():73-90. PubMed ID: 30862553
[TBL] [Abstract][Full Text] [Related]
34. Separation of immunoglobulin G using aqueous biphasic systems composed of cholinium-based ionic liquids and poly(propylene glycol).
Ramalho CC; Neves CMSS; Quental MV; Coutinho JAP; Freire MG
J Chem Technol Biotechnol; 2018 Jul; 93(7):1931-1939. PubMed ID: 30270961
[TBL] [Abstract][Full Text] [Related]
35. Maintaining consistent quality and clinical performance of biopharmaceuticals.
Lamanna WC; Holzmann J; Cohen HP; Guo X; Schweigler M; Stangler T; Seidl A; Schiestl M
Expert Opin Biol Ther; 2018 Apr; 18(4):369-379. PubMed ID: 29285958
[TBL] [Abstract][Full Text] [Related]
36. Extraction and purification methods in downstream processing of plant-based recombinant proteins.
Łojewska E; Kowalczyk T; Olejniczak S; Sakowicz T
Protein Expr Purif; 2016 Apr; 120():110-7. PubMed ID: 26742898
[TBL] [Abstract][Full Text] [Related]
37. Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer Treatment.
Chowdhury MR; Moshikur RM; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
Mol Pharm; 2018 Jun; 15(6):2484-2488. PubMed ID: 29762034
[TBL] [Abstract][Full Text] [Related]
38. Protein crystals for the delivery of biopharmaceuticals.
Basu SK; Govardhan CP; Jung CW; Margolin AL
Expert Opin Biol Ther; 2004 Mar; 4(3):301-17. PubMed ID: 15006725
[TBL] [Abstract][Full Text] [Related]
39. The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing.
Esmonde-White KA; Cuellar M; Lewis IR
Anal Bioanal Chem; 2022 Jan; 414(2):969-991. PubMed ID: 34668998
[TBL] [Abstract][Full Text] [Related]
40. NMR spectroscopy as a characterization tool enabling biologics formulation development.
Ma J; Pathirana C; Liu DQ; Miller SA
J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
